MBIO
MUSTANG BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.52
+6.14%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-40.2%
Return on equity
-19.4%
Return on assets
-46.7%
Return on invested capital
0.00x
Asset turnover
-$4.5M
Cash from operations
$2.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026